The aim of this retrospective observational study is to evaluate the efficacy of antibiotic therapy with dalbavancin in patients presenting with infection on prosthetic devices. The main questions the study aims to answer are: What is the proportion of patients with early discontinuation of dalbavancin therapy? What are the reasons for early discontinuation of antibiotic treatment? What adverse events do patients report? The study is based on data collected as part of routine care practices. Translated with www.DeepL.com/Translator (free version)
Study Type
OBSERVATIONAL
Enrollment
15
Dalbavancin as long-term suppressive therapy.
CH Tourcoing
Tourcoing, France
efficacy of suppressive Dalbavancin therapy
Proportion of patients successfully treated with Dalbavancin. The efficacy of suppressive therapy will be defined over a two-year period after initiation of treatment as the combination of the following criteria: Clinical control of infection : * Absence of local inflammatory signs (erythema, discharge, edema, pain) ; * Absence of general signs (hyperthermia: T°\>38 or hypothermia T°\< 36°); Biological control: o CRP negative (\<5mg/l) ;
Time frame: two-year follow-up after initiation of suppressive therapy with Dalbavancin
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.